[Download] "Shire Presents Positive Data for Patients with Type 1 Gaucher Disease Who Switched to VPRIVTM; Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals Within 4 Years of Initiation of Treatment" by ENP Newswire ~ eBook PDF Kindle ePub Free
eBook details
- Title: Shire Presents Positive Data for Patients with Type 1 Gaucher Disease Who Switched to VPRIVTM; Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals Within 4 Years of Initiation of Treatment
- Author : ENP Newswire
- Release Date : January 26, 2010
- Genre: Business & Personal Finance,Books,
- Pages : * pages
- Size : 89 KB
Description
ENPNewswire-26 March 2010-Shire Presents Positive Data for Patients with Type 1 Gaucher Disease Who Switched to VPRIVTM; Also Reported Are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals within 4 Years of Initiation of Treatment(C)2010 ENPublishing - http://www.enpublishing.co.uk Release date- 25032010 - Cambridge, MA, US - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase. A post-hoc analysis of Phase I/II data on therapeutic goal attainment was also presented at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting in Albuquerque, New Mexico. These data add to the growing body of clinical evidence which support the use of VPRIV in patients both transitioning from imiglucerase or who are treatment naive.
![](http://pinterest.com/pin/create/button/?url=https://rxgrdlnmvc.blogspot.com/2021/07/download-shire-presents-positive-data.html&media=https://is5-ssl.mzstatic.com/image/thumb/Publication/v4/fd/fc/17/fdfc1732-be4b-4c5e-2599-f56d3c248a04/source/700x700bb.jpg&description=[Download] "Shire Presents Positive Data for Patients with Type 1 Gaucher Disease Who Switched to VPRIVTM; Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals Within 4 Years of Initiation of Treatment" by ENP Newswire ~ eBook PDF Kindle ePub Free){kind=link}
Post a Comment for "[Download] "Shire Presents Positive Data for Patients with Type 1 Gaucher Disease Who Switched to VPRIVTM; Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals Within 4 Years of Initiation of Treatment" by ENP Newswire ~ eBook PDF Kindle ePub Free"